Accellix
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2385 Bering Dr, San Jose, California, 95...Phone Number
(650) 396-3035Website
www.accellix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Accellix
Accellix is a biotechnology company dedicated to developing and commercializing the Accellix Platform to enable its customers in the field of cell and gene therapy to meet their critical QC requirements as they advance life changing therapies benefiting patients worldwide. Accellix empowers its customers by migrating their existing cell assays to the Accellix platform. The Accellix platform is a benchtop flow cytometer operating and reading capillary cartridges integrated with dry reagents. It provides unmatched reproducibility and ease of use for automated multi-parametric cell analysis.Explore more
Accellix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accellix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Accellix is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Accellix
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Accellix has new funding data
Check if Accellix has recently received funding, and reach out quickly before it becomes old news!
Accellix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Accellix recently announced quarterly report
Product Launch: Get notified when Accellix launches new products
Click to see if Accellix had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Accellix as Masked Content
Find 3 more new buyers
Compare Similar Companies to Accellix
Compare insights from companies similar to Accellix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Accellix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Accellix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accellix.
Accellix financials insights
Gather financial insights about Accellix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Series D
$9.5M
2021
Private Equity
$10M
Accellix Tech Stack
A closer look at the technologies used by Accellix
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Event
Events, Medical Research, Pharmaceuticals, Clinical Operations, Healthcare Operations, Healthcare Technology
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Accellix News & Media
Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets
SAN JOSE, Calif. & JERUSALEM--(BUSINESS WIRE)-- #biotechnology--Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg Hamilton as Chief Executive Officer and member of the Board effective September 23, 2024. He brings over 25 years of management experience in molecular diagnostics, life science tools, manufacturing and professional service industries as the company ramps growth in cell therapy and blood banks. In conjunctBroadOak Capital Partners invests USD10m in Accellix
BroadOak Capital Partners invests USD10m in Accellix Submitted 14/12/2021 - 9:13am BroadOak Capital Partners has invested USD10 million in Accellix Inc, a provider of flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at the point-of-need. The investment is part of BroadOak’s fifth fund and marks the firm’s third investment in the last six months in the rapidly growing market of tools andAccellix Raises $10 Million From BroadOak Capital Partners
SAN JOSE, Calif. & BETHESDA, Md.--(BUSINESS WIRE)-- #biotechnology--Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at the point-of-need, today announced that it has raised $10 million from BroadOak Capital Partners. BroadOak is known for its flexible growth capital and M&A advice for life sciences tools and services companies. The investment is part of BroadOakAccellix Expands its Leadership Team
SAN JOSE, Calif. & JERUSALEM--(BUSINESS WIRE)-- #biotechnology--Accellix Inc. is pleased to announce that Terrance Gin is joining its leadership team as Vice President Global Operations effective immediately. Terrance brings over 30 years of management experience in IVD manufacturing, process and product development, clinical laboratory operations, quality assurance, capital improvement, facility, and EH&S. He was VP of Operations at Singulex in charge of building the operational functions suppo
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accellix
Sign Up For FreeTo access detailed company insights
Accellix is a biotechnology company dedicated to developing and commercializing the Accellix Platform to enable its customers in the field of cell and gene therapy to meet their critical QC requirements as they advance life changing therapies benefiting patients worldwide. Accellix empowers its customers by migrating their existing cell assays to t... Read More
